Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
Verve Therapeutics Inc (NASDAQ:VERV)
- On April 2, Verve Therapeutics announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in patients with a genetic condition that leads to high cholesterol levels, which raises the risk of heart disease. The treatment is supposed to permanently turn off a protein called PCSK9, which helps reduce blood cholesterol levels. The company's stock fell around 44% over the past month and has a 52-week low of $7.36 .
- RSI Value: 25.88
- VERV Price Action: Shares of Verve Therapeutics fell 8.5% to close at $8.01 on Wednesday.
UnitedHealth Group Inc (NYSE:UNH)
- On April 10, TD Cowen analyst Gary Taylor maintained UnitedHealth with a Buy and lowered the price target from $607 to $546.. The company's stock fell around 8% over the past month. It has a 52-week low of $445.68.
- RSI Value: 27.67
- UNH Price Action: Shares of UnitedHealth fell 2.1% to close at $450.05 on Wednesday.
Gilead Sciences, Inc. (NASDAQ:GILD)
- On April 8, Gilead Sciences said it will release its first quarter 2024 financial results and guidance on Thursday, April 25, 2024, after the closing bell.. The company's stock fell around 10% over the past month and has a 52-week low of $68.06.
- RSI Value: 27.43
- GILD Price Action: Shares of Gilead Sciences fell 2.6% to close at $68.12 on Wednesday.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI 是一種動量指標，它比較股票在價格上漲的日子和價格下跌的日子的走勢。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數低於30時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，RSI接近或低於30。
Verve Therapeutics Inc (NASDAQ:VERV)
Verve Therapeutics Inc（納斯達克股票代碼：VERV）
- On April 2, Verve Therapeutics announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in patients with a genetic condition that leads to high cholesterol levels, which raises the risk of heart disease. The treatment is supposed to permanently turn off a protein called PCSK9, which helps reduce blood cholesterol levels. The company's stock fell around 44% over the past month and has a 52-week low of $7.36 .
- RSI Value: 25.88
- VERV Price Action: Shares of Verve Therapeutics fell 8.5% to close at $8.01 on Wednesday.
- 4 月 2 日，Verve Therapeutics 宣佈了 VERVE-101 的 Heart-1 1b 期試驗的最新進展。正在對患有導致高膽固醇水平的遺傳病患者進行 VERVE-101 評估，這會增加患心臟病的風險。該療法本應永久關閉一種叫做 PCSK9 的蛋白質，它有助於降低血液中的膽固醇水平。該公司的股票在過去一個月中下跌了約44％， 52 周低點爲 7.36 美元 。
- RSI 值：25.88
- VERV價格走勢：週三，Verve Therapeutics的股價下跌8.5％，收於8.01美元。
UnitedHealth Group Inc (NYSE:UNH)
聯合健康集團公司（紐約證券交易所代碼：UNH）
- On April 10, TD Cowen analyst Gary Taylor maintained UnitedHealth with a Buy and lowered the price target from $607 to $546.. The company's stock fell around 8% over the past month. It has a 52-week low of $445.68.
- RSI Value: 27.67
- UNH Price Action: Shares of UnitedHealth fell 2.1% to close at $450.05 on Wednesday.
- 4月10日，道明考恩分析師加里·泰勒維持UnitedHealth的買入，並將目標股價從607美元下調至546美元。該公司的股票在過去一個月中下跌了約8％。它 創下 52 周低點 爲445.68美元。
- RSI 值：27.67
- UNH價格走勢：週三，UnitedHealth的股價下跌2.1％，收於450.05美元。
Gilead Sciences, Inc. (NASDAQ:GILD)
吉利德科學公司（納斯達克股票代碼：GILD）
- On April 8, Gilead Sciences said it will release its first quarter 2024 financial results and guidance on Thursday, April 25, 2024, after the closing bell.. The company's stock fell around 10% over the past month and has a 52-week low of $68.06.
- RSI Value: 27.43
- GILD Price Action: Shares of Gilead Sciences fell 2.6% to close at $68.12 on Wednesday.
- 4月8日，吉利德科學表示，將在收盤後於2024年4月25日星期四發佈其2024年第一季度財務業績和指導。該公司的股票在過去一個月中下跌了約10％，爲期52周 低點爲68.06美元。
- RSI 值：27.43
- GILD價格走勢：週三，吉利德科學股價下跌2.6％，收於68.12美元。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧